Search For "antibody"
Lilly India gets nod for use of monoclonal antibody drugs for treating Cov
Updated : 4 years, 9 months ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 mg and etesevimab 1,400 mg in India for treatment of patients with mild to moderate coronavirus disease 2019 (Covid-19).
Read More
Monoclonal antibodies to treat COVID patients should always be used in pai
Updated : 4 years, 9 months ago IST
New Delhi [India], May 31 (ANI): Monoclonal antibodies, recently introduced in India as an antibody therapy to treat COVID-positive patients, are being used to minimise mutation formation and should always be used in a pair, said Dr Nirmal K Ganguly, former Director-General of the Indian Cou
Read More
Monoclonal antibody cocktail unlikely to cause further mutations of COVID-
Updated : 4 years, 9 months ago IST
New Delhi [India], May 30 (ANI): Monoclonal antibody cocktail, used for the treatment of COVID-19, is unlikely to lead to further mutation of the virus, said Dr Raman R Gangakhedkar, former Head Scientist of Epidemiology and Communicable Diseases at the Indian Council of Medical Research (IC
Read More
Efficient manufacturing system needed to lower cost of Monoclonal antibody
Updated : 4 years, 9 months ago IST
New Delhi [India], May 30 (ANI): The cost of Monoclonal antibody therapy, which was recently approved by India's top drug regulatory body for treatment of COVID-19, can be lowered if a very efficient system for its manufacturing is developed, said Dr Nirmal K Ganguly, former Director-General
Read More
COVID-19: Indigenous monoclonal antibodies drug's production at low cost c
Updated : 4 years, 9 months ago IST
New Delhi [India], May 30 (ANI): Monoclonal antibody drug production in India at reasonable price could be a "game changer" for the country in its fight against COVID-19, said Dr Arvinder S Soin, Chairman, Institute of Liver Transplant and Regenerative Medicine at Medanta Hospital on Sunday.
Read More
Tamil Nadu's first SARS-CoV-2 antibody cocktail treatment for COVID-19 beg
Updated : 4 years, 9 months ago IST
Chennai (Tamil Nadu) [India], May 28 (ANI/NewsVoir): A new entrant into the treatment portfolio of COVID-19 in India is the cocktail formulation of Mono Clonal Antibodies (MCAb).
Read More
COVID antibody cocktail now offered to patients at Indraprastha Apollo Hos
Updated : 4 years, 9 months ago IST
New Delhi [India], May 28 (ANI): Roche India's Antibody Cocktail (Casirivimab and Imdevimab) is now available as a therapy to treat patients with mild and moderate COVID-19 infection at the Indraprastha Apollo Hospitals in Delhi, the hospital said in a statement on Friday.
Read More
First COVID-19 patient treated with antibodies cocktail in India discharge
Updated : 4 years, 9 months ago IST
Gurugram (Haryana) [India], May 26 (ANI): An 84-year-old man from Haryana with multiple co-morbidities was discharged from Medanta hospital after getting the jap of monoclonal antibody cocktail. He has become the first person in India to be administered the COVID drug cocktail, which came i
Read More
84-yr-old Haryana man, first in India to get antibody cocktail against Cov
Updated : 4 years, 9 months ago IST
Gurugram (Haryana) [India], May 26 (ANI): An 84-year-old man from Haryana has become the first person in India to be administered the Covid drug cocktail, which came into limelight after it was administered to former US President Donald Trump when he tested positive for the virus last yea
Read More
Mild COVID-19 induces lasting antibody protection: Study
Updated : 4 years, 9 months ago IST
Washington [US], May 25 (ANI): Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19. Such cells could persist for a lifetime, churning out antibodies all the while, suggested a new stud
Read More
COVID antibody cocktail used to treat Donald Trump now launched in India
Updated : 4 years, 9 months ago IST
New Delhi [India], May 24 (ANI): Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose.
Read More
Bengaluru-based start-up develops ELISA test for accurate detection of COV
Updated : 4 years, 9 months ago IST
New Delhi [India], May 22 (ANI): A Bangalore-based start-up has developed a novel, point-of-care Electrochemical ELISA test to estimate accurate antibody concentration of COVID-19 in clinical samples, informed the Union Science and Technology Ministry on Saturday.
Read More